A detailed history of Coldstream Capital Management Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 3,451 shares of ITCI stock, worth $294,163. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,451
Previous 3,369 2.43%
Holding current value
$294,163
Previous $230,000 9.57%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$67.99 - $80.84 $5,575 - $6,628
82 Added 2.43%
3,451 $252,000
Q2 2024

Aug 07, 2024

SELL
$64.76 - $79.84 $24,090 - $29,700
-372 Reduced 9.94%
3,369 $230,000
Q1 2024

May 13, 2024

BUY
$64.37 - $75.65 $3,282 - $3,858
51 Added 1.38%
3,741 $258,000
Q4 2023

Feb 09, 2024

BUY
$46.37 - $73.65 $171,105 - $271,768
3,690 New
3,690 $264,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.05B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.